Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Yung-Chieh Chang
Observed names:
Y C Chang,
Y. C. Chang
Institutions:
National Health Research Institutes,
Taipei Medical University Hospital,
Taipei Medical University,
National Cheng Kung University
Observed institutions:
National Health Research Institutes,
Tzu Chi Foundation,
Taipei Medical University Hospital,
National Cheng Kung University Hospital,
Taipei Medical University,
National Cheng Kung University
show all 6
ORCID:
0000-0002-8699-2834
Observed ORCID:
0000-0002-8699-2834
OpenAlex ID:
A5081251572
Survivin – biology and potential as a therapeutic target in oncology
2013
·
Jang-Yang Chang
, Chun Hei Antonio Cheung
, et al.
·
OncoTargets and Therapy
·
148
PDF
BIRC5/Survivin is a novel ATG12–ATG5 conjugate interactor and an autophagy-induced DNA damage suppressor in human cancer and mouse embryonic fibroblast cells
2019
·
Tzu-Yu Lin
, Hsiu-Han Chan
, et al.
·
Autophagy
·
136
PDF
YM155 down‐regulates survivin and XIAP , modulates autophagy and induces autophagy‐dependent DNA damage in breast cancer cells
2014
·
S M Cheng
, Y C Chang
, et al.
·
British Journal of Pharmacology
·
93
PDF
Malignancy may adversely influence the quality and behaviour of oocytes
1998
·
L. Pal
, L. Leykin
, et al.
·
Human Reproduction
·
67
Mutation of the PTCH1 gene predicts recurrence of breast cancer
2019
·
Chih-Yang Wang
, Yung-Chieh Chang
, et al.
·
Scientific Reports
·
58
PDF
An Updated Review of Smac Mimetics, LCL161, Birinapant, and GDC-0152 in Cancer Treatment
2020
·
Yung-Chieh Chang
, Chun Hei Antonio Cheung
·
Applied Sciences
·
44
PDF
HDAC2 and HDAC5 Up-Regulations Modulate Survivin and miR-125a-5p Expressions and Promote Hormone Therapy Resistance in Estrogen Receptor Positive Breast Cancer Cells
2017
·
Wen-Tsung Huang
, Yu-Hsuan Tsai
, et al.
·
Frontiers in Pharmacology
·
36
PDF
The SMAC mimetic LCL161 is a direct ABCB1/MDR1-ATPase activity modulator and BIRC5/Survivin expression down-regulator in cancer cells
2020
·
Yung-Chieh Chang
, Sree Karani Kondapuram
, et al.
·
Toxicology and Applied Pharmacology
·
35
YM155 and BIRC5 downregulation induce genomic instability via autophagy-mediated ROS production and inhibition in DNA repair
2021
·
Siao Muk Cheng
, Tzu-Yu Lin
, et al.
·
Pharmacological Research
·
33
CXCR7 activation evokes the anti-PD-L1 antibody against glioblastoma by remodeling CXCL12-mediated immunity
2024
·
Chan-Chuan Liu
, Wen-Bin Yang
, et al.
·
Cell Death and Disease
·
11
Cloning, expression, and purification of the recombinant pro-apoptotic dominant-negative survivin T34A-C84A protein in Escherichia coli
2019
·
Shing-Ling Tsai
, Yung-Chieh Chang
, et al.
·
Protein Expression and Purification
·
10
The SMAC mimetic GDC-0152 is a direct ABCB1-ATPase activity modulator and BIRC5 expression suppressor in cancer cells
2024
·
I-Li Lin
, Yu-Ting Lin
, et al.
·
Toxicology and Applied Pharmacology
·
8
NUPR1 contributes to endocrine therapy resistance by modulating BIRC5 expression and inducing luminal B-ERBB2+ subtype-like characteristics in estrogen receptor-positive breast cancer cells
2025
·
Chun-Hui Lee
, Yi-Chen Lin
, et al.
·
Journal of Cancer
·
5
PDF
EGFRvIII-driven microenvironmental fibroblast activation and transformation accelerate oral cancer progression via lipocalin-2/STAT3 axis
2025
·
Hsuan-Yu Peng
, Kwang-Yu Chang
, et al.
·
Neoplasia
·
4
Unraveling Cathepsin S regulation in interleukin-7-mediated anti-tumor immunity reveals its targeting potential against oral cancer
2025
·
Yung-Chieh Chang
, Szu-Jung Chen
, et al.
·
Journal of Biomedical Science
·
2
BIRC5 Promoter-Driven Nanodrugs Suppress BIRC5-Positive Cancers Independent of ABCB1 Status and IDO1 Expression
2026
·
Yung-Chieh Chang
, Wei-Lun Huang
, et al.
·
International Journal of Nanomedicine
·
1
Abstract 5966: Cathepsin S mediates interleukin 7 to sculpture the tumor immunity in head and neck cancer
2023
·
Yung-Chieh Chang
, Shan-Hung Chen
, et al.
·
Cancer Research
·
1
Tumor-derived RPS19 engages C5AR1+ inflammatory macrophages to drive astrocyte reprogramming and glioblastoma progression
2026
·
Chan-Chuan Liu
, Cheng-Lin Wu
, et al.
·
Cell Communication and Signaling
Discovery of a novel miconazole analogue as a dual apo-IDO1 inhibitor and ABCB1 modulator for cancer immunotherapy and chemosensitizing
2026
·
Pin-Chen Chen
, Yung-Chieh Chang
, et al.
·
European Journal of Pharmaceutical Sciences
PDF
Synergistic enhancement of PD-L1 expression from DNA repair dysfunction and UV exposure in xeroderma pigmentosum: Potential therapeutic role of PD-L1 inhibitors
2026
·
Yu-Chen Lin
, Tzu-Yu Lin
, et al.
·
Journal of Dermatological Science
Egfrviii-Driven Microenvironmental Fibroblast Activation and Transformation Accelerate Oral Cancer Progression Via Lipocalin-2/Stat3 Axis
2025
·
Jang-Yang Chang
, Hsuan-Yu Peng
, et al.
·
SSRN Electronic Journal
P271 Impact of Biologics on Surgical Trends in Inflammatory Bowel Disease: Insights from a Lower-endemic Region
2024
·
C H Chuang
, E H Yang
, et al.
·
Journal of Crohn s and Colitis
PDF
A Boy With Abdominal Pain and Vomiting
2023
·
Min-Chun Chen
, Yung-Chieh Chang
, et al.
·
Annals of Emergency Medicine
PDF
Is pinworm infection still a public health concern among children in resource-rich region? The prevalence and time-trend analysis of pinworm infection among school-aged children in Hualien County, Taiwan: A retrospective longitudinal study
2022
·
Yu-Chao Hsiao
, Jen-Hung Wang
, et al.
·
Research Square
PDF
Show more works
View as search
Works count:
24
Citation count:
692
H-index:
10
I10-index:
11
Year
Topic
Type